These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2714332)

  • 1. Stone formation and urine composition in calcium stone formers without medical treatment.
    Bek-Jensen H; Tiselius HG
    Eur Urol; 1989; 16(2):144-50. PubMed ID: 2714332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C; Larsson L; Tiselius HG
    Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
    Tiselius HG; Sandvall K
    Eur Urol; 1990; 17(3):206-12. PubMed ID: 2351189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
    Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical relationship between urine composition and urinary stone formation in stone forming patients.
    Abdel-Aziz AF; el-Waseef A; Abou el-Fotouh M
    Int Urol Nephrol; 1996; 28(4):457-64. PubMed ID: 9119628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of calcium stone formation in patients with primary Sjögren's syndrome.
    Eriksson P; Denneberg T; Tiselius HG
    Urol Res; 1996; 24(1):39-43. PubMed ID: 8966840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate.
    Jendle-Bengten C; Tiselius HG
    Scand J Urol Nephrol; 2000 Feb; 34(1):36-41. PubMed ID: 10757268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation.
    Berg C; Larsson L; Tiselius HG
    J Urol; 1992 Sep; 148(3 Pt 2):979-85. PubMed ID: 1507355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
    Trinchieri A; Lizzano R; Marchesotti F; Zanetti G
    Urol Res; 2006 Feb; 34(1):1-7. PubMed ID: 16425021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.